Hepatitis C Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study
Conditions:   Inflammatory Bowel Diseases;   Hepatitis C Virus Infection Interventions:   Drug: Assess the effectiveness and safety of DAAs in patients with IBD.;   Drug: Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics.;   Other: Assessment of the impact of DAAs on the course of IBD. Sponsor:   Hospital Mutua de Terrassa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials

Hepatitis C Treatment in Probation and Parole Office
Conditions:   Hepatitis C;   HCV Intervention:   Behavioral: Telehealth in Parole/Probation Office Sponsors:   Jens Rosenau;   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials